Biotest AG (GB:0N6Z)
LSE:0N6Z
Holding GB:0N6Z?
Track your performance easily

Biotest (0N6Z) Financial Statements

0 Followers

Biotest Financial Overview

Biotest's market cap is currently ―. The company's EPS TTM is €4.154; its P/E ratio is 5.95; and it has a dividend yield of 0.16%. Biotest is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue€ 155.30M€ 107.70M€ 137.20M€ 115.90M€ 144.20M
Gross Profit€ 44.20M€ 23.60M€ 30.80M€ 26.20M€ -1.00M
EBIT€ -5.00M€ -4.40M€ -1.20M€ -600.00K€ -43.10M
EBITDA€ -5.00M€ -4.40M€ -1.20M€ -600.00K€ -43.10M
Net Income Common Stockholders€ 2.10M€ -14.30M€ -15.00M€ -4.90M€ -35.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 136.60M€ 76.90M€ 103.10M€ 130.10M€ 117.50M
Total Assets€ 1.20B€ 1.08B€ 1.10B€ 1.11B€ 1.10B
Total Debt€ 574.30M€ 0.00€ 0.00€ 0.00€ 496.30M
Net Debt€ 437.70M€ -76.90M€ -103.10M€ -130.10M€ 378.80M
Total Liabilities-€ 735.50M€ 743.20M€ 734.70M€ 723.80M
Stockholders Equity€ 371.10M€ 343.80M€ 358.70M€ 375.10M€ 380.40M
Cash Flow-
Free Cash Flow€ -53.00M€ -18.70M€ -18.10M€ 20.00M€ 12.40M
Operating Cash Flow€ -23.70M€ -18.70M€ -18.10M€ 20.00M€ 30.60M
Investing Cash Flow€ -12.20M€ -9.30M€ -7.80M€ -7.70M€ -4.00M
Financing Cash Flow€ 99.20M€ -3.80M€ -4.30M€ -1.50M€ -1.50M
Currency in EUR

Biotest Earnings and Revenue History

Biotest Debt to Assets

Biotest Cash Flow

Biotest Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis